HHS Logo U.S. Department of Health & Human Services Divider arrowNIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
Cures Acceleration Network (CAN) Review Board

Alan Palkowitz (2019)

Alan PalkowitzDr. Palkowitz is the Vice President of Discovery Chemistry Research and Technologies at Eli Lilly and Company. He is responsible for the global small molecule strategy and delivery of clinical candidates in all areas of disease focus including cancer, diabetes, immunology, pain and neurodegenerative disorders. Within Discovery Chemistry Research and Technologies, Dr. Palkowitz oversees a large multi-research site enterprise that includes medicinal chemistry, computational and biophysical/structural sciences, quantitative biology, analytical technologies, synthetic technologies and automation sciences. In his role Dr. Palkowitz has championed the creation of multiple molecular discovery strategies, along with supporting infrastructure, to diversify approaches to drug discovery and successfully expand therapeutic innovation. In addition, he has implemented unique open innovation business models aimed at expanding global access to diverse talent and capabilities in partnership with academic centers and small biotechs. At Lilly, Dr. Palkowitz also serves as a member of several executive oversight committees that set strategic scientific direction for the company.

Last updated: 01-06-2017
▲ Back to top